RESUMO
Information regarding the curative role of allogeneic stem cell transplantation (allo-HCT) in systemic anaplastic large cell lymphoma (sALCL) is scarce. We analyzed the results of allo-HCT in patients with relapsed/refractory sALCL with special emphasis on the role of brentuximab vedotin (BV) as a bridge to allo-HCT. Forty-four patients (24 females, median age 38 years) with sALCL were included. Twenty-three patients (52%) received BV before allo-HCT; BV-treated patients were more heavily pretreated (≥3 lines of therapy in 74% vs. 38%, p = 0.04). Twenty-three patients (52%) were in complete remission (CR) at allo-HCT. Three-year nonrelapse mortality and incidence of relapse (IR) after allo-HCT were 7% and 40%, respectively. With a median follow-up of 39 (12-69) months for survivors, 3-year progression-free survival (PFS) and overall survival were 53% and 74%, respectively. Univariate analysis showed that heavily pretreated patients and those not in CR had a higher IR and a lower PFS. The use of BV before transplant did not impact on any of the outcomes. Allo-HCT is a curative therapeutic strategy in a significant proportion of patients with relapsed/refractory sALCL; BV does not seem to modify transplant-related outcomes but might be able to render more patients candidates for this curative treatment.
Assuntos
Transplante de Células-Tronco Hematopoéticas , Imunoconjugados , Linfoma Anaplásico de Células Grandes , Adulto , Medula Óssea , Feminino , Humanos , Imunoconjugados/uso terapêutico , Linfoma Anaplásico de Células Grandes/terapia , Recidiva Local de Neoplasia , Estudos Retrospectivos , Condicionamento Pré-TransplanteRESUMO
Systemic anaplastic large cell lymphoma (sALCL) is a rare histological entity expressing the CD30 antigen that comprises around 11% of peripheral T-cell lymphoma. We analysed the outcome of patients with relapsed/refractory sALCL treated with autologous stem cell transplantation (auto-HCT). We included 65 adult patients (42 males; median age, 44 years); 24 patients had an ALK-ve sALCL. Fifty-one patients had chemosensitive disease at the time of transplant. Ten patients (15%) were treated with brentuximab vedotin (BV) before auto-HCT (median number of doses: 5). The median follow-up for surviving patients was 35 months (3-71). Three-year cumulative incidence of nonrelapse mortality and of relapse were 1.7% and 34%, respectively. Three-year progression-free survival and overall survival were 64% and 73%, respectively. No prognostic factors for any of the outcomes analysed were found in univariate analysis. There were no significant differences in any of the outcomes between patients who had received BV and the remainder. This is the largest analysis presented so far analysing the role of auto-HCT in patients with relapsed/refractory sALCL, showing a promising PFS and OS in this high-risk population. The potential impact of the administration of BV as salvage strategy before the procedure needs to be further elucidated.
Assuntos
Transplante de Células-Tronco Hematopoéticas , Imunoconjugados , Linfoma Anaplásico de Células Grandes , Adulto , Humanos , Linfoma Anaplásico de Células Grandes/terapia , Masculino , Recidiva Local de Neoplasia , Estudos Retrospectivos , Transplante AutólogoAssuntos
Doenças do Pé/patologia , Mieloma Múltiplo/patologia , Plasmócitos/patologia , Neoplasias Cutâneas/patologia , Idoso , Biomarcadores Tumorais/análise , Diagnóstico Diferencial , Progressão da Doença , Feminino , Doenças do Pé/metabolismo , Calcanhar , Humanos , Imunoglobulina A/análise , Cadeias kappa de Imunoglobulina/análise , Mieloma Múltiplo/química , Proteínas do Mieloma/análise , Neoplasias Primárias Múltiplas/diagnóstico , Plasmócitos/química , Plasmocitoma/diagnóstico , Neoplasias Cutâneas/química , Neoplasias Cutâneas/diagnósticoRESUMO
BACKGROUND: Metaplastic breast carcinoma (MBC) is a rare type of breast cancer that has basal-like characteristics and is perceived to have poorer prognosis when compared with conventional no specific type/ductal carcinomas (ductal/NST). However, current data on MBC are largely derived from small case series or population-based reports. This study aimed to assess the clinicopathological features and outcome of MBC identified through an international multicentre collaboration. METHODS: A large international multicentre series of MBC (no=405) with histological confirmation and follow-up information has been included in this study. The prognostic value of different variables and outcome has been assessed and compared with grade, nodal status and ER/HER2 receptor-matched ductal/NST breast carcinoma. RESULTS: The outcome of MBC diagnosed in Asian countries was more favourable than those in Western countries. The outcome of MBC is not different from matched ductal/NST carcinoma but the performance of the established prognostic variables in MBC is different. Lymph node stage, lymphovascular invasion and histologic subtype are associated with outcome but tumour size and grade are not. Chemotherapy was associated with longer survival, although this effect was limited to early-stage disease. In this study no association between radiotherapy and outcome was identified. Multivariate analysis of MBC shows that histologic subtype is an independent prognostic feature. CONCLUSIONS: This study suggests that MBC is a heterogeneous disease. Although the outcome of MBC is not different to matched conventional ductal/NST breast carcinoma, its behaviour is dependent on the particular subtype with spindle cell carcinoma in particular has an aggressive biological behaviour. Management of patients with MBC should be based on validated prognostic variables.
Assuntos
Neoplasias da Mama/patologia , Carcinoma Ductal de Mama/secundário , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias da Mama/mortalidade , Neoplasias da Mama/terapia , Carcinoma Ductal de Mama/mortalidade , Carcinoma Ductal de Mama/terapia , Feminino , Humanos , Estimativa de Kaplan-Meier , Metástase Linfática , Pessoa de Meia-Idade , Prognóstico , Modelos de Riscos Proporcionais , Resultado do TratamentoRESUMO
UNLABELLED: Metaplastic carcinoma with chondroid differentiation (MMPC) is a subtype of breast metaplastic carcinoma with mesenchymal differentiation. Although fine-needle aspiration (FNAB) and core-needle biopsy (CNB) are commonly used for the diagnosis of breast cancer, not enough studies proving the diagnostic cost-effectiveness of these techniques for the identification of MMPC have been published so far. The aim of this study was to investigate the concordance between the presurgical diagnosis using FNAB/CNB and the definitive diagnosis in the surgical specimen in pure MMPC. A case of MMPC is also reported. STUDY DESIGN: All cases of MMPC diagnosed in our institution from 1995 to 2011 were reviewed. The presence of chondroid differentiation in cytological studies or biopsies and the proportion of chondroid matrix in the surgical specimen were evaluated. RESULTS: A total of 13 cases of pure MMPC were collected. The diagnosis was suspected in 25% of FNABs and was rendered in 40% of CNBs. CONCLUSIONS: The chondroid component in MMPC is hard to identify by FNAB and CNB. The random distribution and proportion of the chondroid differentiation in the tumour and the expertise in performing the technique and in identifying the chondroid component may play an important role in the diagnosis of MMPC using these techniques.
Assuntos
Biópsia por Agulha Fina/economia , Biópsia com Agulha de Grande Calibre/economia , Neoplasias da Mama/diagnóstico , Carcinoma/diagnóstico , Adulto , Idoso , Análise Custo-Benefício , Feminino , Humanos , Pessoa de Meia-IdadeRESUMO
Diffuse large b-cell lymphoma (DLBCL) is an aggressive and potentially curable lymphoma that presents itself as stage I-II in 30% of all cases. It is known that in these localized stages, 15-20% of patients treated without rituximab eventually relapse, but less data exist regarding rituximab era. We have analyzed clinico-pathological features and risk of relapse in 98 patients with I-II stage DLBCL in complete response (CR) or unconfirmed CR (CRu) after first-line treatment consisting of immunochemotherapy. Twelve patients (12.2%) eventually relapsed. Late relapse, more than two years after diagnosis, occurred in three patients, and early relapse, less than two years after diagnosis, was documented in nine patients. Median time from diagnosis to relapse was 0.61 years for patients with early relapse and 3.66 years for patients with late relapse. The second CR rate obtained was similar in the late and in early relapsing patients, being 33% versus 44% (p = 0.072), respectively. Three-year overall survival (OS) was 22% for early relapsing patients and 33% for late relapsing patients (p = 0.65). In conclusion, patients who are diagnosed with stage I-II DLBCL and achieve a CR/CRu with first line immunochemotherapy have a good prognosis. However, a proportion of patients relapse, and this is less frequent in patients treated with first line with immunochemotherapy. These patients have a poor prognosis.
RESUMO
REASONS FOR PERFORMING THE STUDY: In man, peritoneal transforming growth factor beta (TGF-beta) is associated with peritoneal diseases and subsequent adhesion formation. No studies on plasma and peritoneal TGF-beta concentrations in horses with colic are available. OBJECTIVES: 1) To determine both plasma and peritoneal TGF-beta(1) and TGF-beta(3) concentrations in horses with different types of colic (not previously subjected to abdominal surgery); 2) to compare these concentrations according to the type of peritoneal fluid (transudate, modified transudate and exudate); and 3) to compare and correlate plasma and peritoneal concentrations of TGF-beta(1) and TGF-beta(3) and the types of peritoneal fluid according to the colic group and outcome. METHODS: Peritoneal fluid and plasma samples from 78 horses with colic and 8 healthy horses were obtained. Patients were classified according to diagnosis (obstructions, enteritis, ischaemic disorders and peritonitis), peritoneal fluid analysis (transudate, modified transudate and exudate), and outcome (survivors and nonsurvivors). Plasma and peritoneal TGF-beta(1) and TGF-beta(3) concentrations were determined by ELISA. Data were analysed by parametric and nonparametric tests. P< or =0.05 was considered as statistically significant. RESULTS: Concentrations of peritoneal fluid TGF-beta(1) were significantly (P = 0.01) higher in horses with peritonitis in comparison with all other colic groups and controls. Horses with ischaemic lesions had significantly (P = 0.01) higher concentrations of peritoneal TGF-beta(1) in comparison with controls and the group of horses with obstructions. Peritoneal TGF-beta(1) concentration also was significantly (P = 0.01) higher in exudates in comparison with transudates. Peritoneal TGF-beta(1) and TGF-beta(3) concentrations and plasma TGF-beta(1) concentration were significantly increased in nonsurvivors compared to survivors (P = 0.001, P = 0.004 and P = 0.05, respectively). CONCLUSIONS: Peritoneal TGF-beta(1) concentration was higher in horses with severe gastrointestinal diseases (ischaemic intestinal lesions and peritonitis), in horses with an altered peritoneal fluid (exudate), and in nonsurvivors. POTENTIAL RELEVANCE: Peritoneal TGF-beta concentration increases in horses with severe gastrointestinal disease as an anti-inflammatory response.
Assuntos
Líquido Ascítico/química , Cólica/veterinária , Doenças dos Cavalos/metabolismo , Fator de Crescimento Transformador beta/análise , Fator de Crescimento Transformador beta/sangue , Animais , Líquido Ascítico/metabolismo , Cólica/metabolismo , Cavalos , Fator de Crescimento Transformador beta/metabolismoAssuntos
Coxeadura Animal/etiologia , Mononeuropatias/veterinária , Animais , Antibacterianos/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Axônios , Dimetil Sulfóxido/uso terapêutico , Sequestradores de Radicais Livres/uso terapêutico , Membro Posterior/patologia , Cavalos , Masculino , Mononeuropatias/complicações , Fenilbutazona/análogos & derivados , Fenilbutazona/uso terapêutico , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico , Vitamina E/uso terapêuticoRESUMO
Eight mares with third-degree rectovestibular lacerations were treated by a two-stage surgical technique. The rectovestibular shelf was corrected with three parallel 'circular' continuous suture rows distributed along the longitudinal axis of the vagina, and the perineal body was reconstructed with three divergent simple continuous rows. Primary healing of the first-stage surgery occurred in all the mares. Seven of the mares completed the two-stage surgery and primary healing occurred in all of them. One of them returned to endurance racing competition and one was lost to follow-up. The other five were bred and became pregnant; one foaled four times, two foaled three times, one foaled once and the other was pregnant at the time of writing. The condition did not recur in any of the mares after foaling.
Assuntos
Doenças dos Cavalos/cirurgia , Períneo/lesões , Fístula Retovaginal/veterinária , Técnicas de Sutura/veterinária , Animais , Feminino , Cavalos , Períneo/cirurgia , Gravidez , Fístula Retovaginal/cirurgia , Recidiva , Reprodução , Cicatrização , Ferimentos e Lesões/cirurgia , Ferimentos e Lesões/veterináriaRESUMO
The pattern of expression by using in situ hybridization in whole mouse embryos of the neuroleukin/glucose-6-phosphate isomerase (NK/GPI) gene and its receptor (AMF-R) is reported. NK/GPI expression was first seen at embryonic day 9 whereas AMF-R was detected at embryonic day 8; both were detected up to day 12 with NK/GPI showing peaking in the limbs around day 11. The main regions of expression are limb buds, spinal cord and brain. This work contributes to understanding how both proteins act in the development of somatosensory and motoric neural structures.
Assuntos
Regulação da Expressão Gênica no Desenvolvimento , Glucose-6-Fosfato Isomerase/metabolismo , Camundongos/embriologia , Animais , Idade Gestacional , Glucose-6-Fosfato Isomerase/genética , Hibridização In Situ/métodos , Hibridização In Situ/veterináriaRESUMO
Two horses with acute tendinopathy of a superficial digital flexor tendon (SDFT) and three horses with chronic proximal desmitis of the suspensory ligament (PDSL) were treated by injecting autologous concentrates of their platelets into the lesions. The lesions were monitored ultrasonographically and clinically. There were significant ultrasonographic and clinical improvements in the two horses with SDFT, but no ultrasonographic improvements in the horses with PDSL; however, they improved clinically and became less lame. All the horses had returned to their pre-injury level of performance by six months after the completion of the treatment, and none of them had suffered a recurrence after 20 months.
Assuntos
Plaquetas , Doenças dos Cavalos/terapia , Doenças Musculoesqueléticas/veterinária , Tendinopatia/veterinária , Animais , Feminino , Doenças dos Cavalos/diagnóstico por imagem , Doenças dos Cavalos/patologia , Cavalos , Coxeadura Animal , Ligamentos/diagnóstico por imagem , Ligamentos/patologia , Masculino , Doenças Musculoesqueléticas/diagnóstico por imagem , Doenças Musculoesqueléticas/patologia , Doenças Musculoesqueléticas/terapia , Tendinopatia/diagnóstico por imagem , Tendinopatia/patologia , Tendinopatia/terapia , Tendões/diagnóstico por imagem , Tendões/patologia , Resultado do Tratamento , Ultrassonografia/veterináriaRESUMO
Eosinophilic synovitis (ES) is a rare disease described in human and veterinary medicine. Only three cases have been reported in the horse. A case of tarsocrural synovitis in an Hispano-Arabian gelding is presented in this report. The patient presented with severe joint effusion and lameness of the right tarsocrural joint on admission. Synovial fluid analysis revealed an increased WBC of 12800 leukocytes/microliter with 76% of eosinophils. Lavage of the diseased joint and medical treatment with antibiotics and non-steroidal anti-inflammatory drugs produced remission of the clinical problem.
Assuntos
Antibacterianos/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Doenças dos Cavalos/diagnóstico , Líquido Sinovial/citologia , Sinovite/veterinária , Animais , Eosinófilos , Doenças dos Cavalos/tratamento farmacológico , Cavalos , Coxeadura Animal , Contagem de Leucócitos/veterinária , Masculino , Sinovite/diagnóstico , Sinovite/tratamento farmacológico , Resultado do TratamentoRESUMO
Amyotrophic lateral sclerosis is a progressive degenerative neuromuscular disease of insidious onset. It involves upper and lower motor neurons and causes both spastic and atrophic muscular symptoms. More than one fourth of patients have complaints relating to the head and neck (bulbar palsy); thus, the otolaryngologist may be the first physician to see them. In bulbar forms of Amyotrophic Lateral Sclerosis, voice and/or swallowing difficulties are often the initial signs of disturbance. Predominant symptoms are slurred speech, hoarseness, dysphagia, and dyspnea. Muscular weakness, atrophy, and fasciculation are noted on examination. We show a case and revise bibliography.
Assuntos
Esclerose Lateral Amiotrófica/complicações , Transtornos de Deglutição/etiologia , Distúrbios da Voz/etiologia , Feminino , Humanos , Pessoa de Meia-IdadeRESUMO
First-trimester prenatal diagnosis was undertaken by chorionic villus DNA analysis in a Spanish family with the inherited Glu104Asp triose-phosphate isomerase deficiency. The fetus was heterozygous for the mutation and therefore predicted to be clinically unaffected. To investigate the evolutionary origin of this mutation, studies were conducted on the intragenic 2262A/G polymorphism and the CD4 pentameric tandem repeat marker. A different haplotype was found to the one previously described, suggesting a different origin of the Spanish mutation.
Assuntos
Ácido Aspártico/metabolismo , Ácido Glutâmico/metabolismo , Haplótipos , Mutação , Diagnóstico Pré-Natal/métodos , Triose-Fosfato Isomerase/deficiência , Antígenos CD4/genética , Enzimas de Restrição do DNA/metabolismo , Evolução Molecular , Saúde da Família , Feminino , Heterozigoto , Humanos , Reação em Cadeia da Polimerase , Polimorfismo Genético , Gravidez , Análise de Sequência de DNA , Espanha , Triose-Fosfato Isomerase/genéticaRESUMO
Metabolic alterations have been characterized in various heart diseases. However, no data are available concerning metabolic changes during acute rejection episodes. Heterotopic heart transplantations in rats were done using Lewis rats as donors and recipients as a control group. The rejection group included Brown-Norway rat donors to Lewis rat recipients. Nonoperated hearts were also studied. Enzyme activities were determined for phosphofructokinase, pyruvate kinase, and lactate dehydrogenase. There were no alterations in the control group compared to nonoperated hearts. However, the rejection cohort of hearts showed decreased glycolytic enzymes. Although lactate dehydrogenase maintained similar levels compared to the control group, phosphofructokinase showed only 50% activity, and pyruvate kinase showed less than 10% of the activity compared with controls. These results suggested that metabolic alterations in rejected hearts differ from other cardiomyopathies.
Assuntos
Glicólise , Rejeição de Enxerto/enzimologia , Transplante de Coração/imunologia , Doença Aguda , Animais , Modelos Animais de Doenças , Transplante de Coração/patologia , L-Lactato Desidrogenase/metabolismo , Fosfofrutoquinases/metabolismo , Piruvato Quinase/metabolismo , Ratos , Ratos Endogâmicos BN , Ratos Endogâmicos Lew , Transplante Homólogo , Transplante IsogênicoRESUMO
On the scarring strictures at the level of the pharyngo-esophageal junction, for example following surgery for pharyngo-laryngeal tumours, the treatment was traditionally the use of transoral dilators, as the metallic spark plugs or olives. At present the balloon catheters are the election technique for all cases. The advantages for the balloon catheters versus the traditional methods are the smaller morbidity and mortality, the effectiveness, simplicity and little cost. We show the protocol done in our center for the dilation of these strictures.
Assuntos
Cateterismo , Estenose Esofágica/terapia , Doenças Faríngeas/terapia , Cateterismo/efeitos adversos , Cateterismo/métodos , Constrição Patológica/diagnóstico por imagem , Constrição Patológica/terapia , Fístula Esofágica/etiologia , Perfuração Esofágica/etiologia , Estenose Esofágica/diagnóstico por imagem , Hemorragia/etiologia , Humanos , Doenças Faríngeas/diagnóstico por imagem , Radiografia , StentsRESUMO
The Rhodococcus equi is an aerobic gram positive pleomorphic bacillus, that was isolated for the first time like a producer of bronchopneumonia in young horses. Every time more often, it is being recognized as a pathogen in humans, mainly in the immunodepressed population. We described a case, until now exceptional, of laryngeal infection by Rhodococcus equi in a patient with positive serology for the virus of the human immunodeficiency (HIV), and we reviewed some clinical and epidemiological characteristics of the infections by this germ. The treatment is riphampicine and/or erythromycin, being the prognosis bad, because usually they are immunodepressed patients.
Assuntos
Síndrome da Imunodeficiência Adquirida/complicações , Infecções por Actinomycetales/microbiologia , Laringite/complicações , Laringite/microbiologia , Rhodococcus equi/isolamento & purificação , Infecções por Actinomycetales/tratamento farmacológico , Adulto , Antibacterianos/uso terapêutico , Antibióticos Antituberculose/uso terapêutico , Quimioterapia Combinada , Eritromicina/uso terapêutico , Humanos , Mucosa Laríngea/microbiologia , Mucosa Laríngea/patologia , Laringite/tratamento farmacológico , Masculino , Rifampina/uso terapêuticoRESUMO
Tumors of minor nasal salivary glands are relatively sparse. The case reported is a monomorph adenoma of benign character, which first clinical diagnosis mimicked a naso-sinusal polyposis. Examination of the removed piece by functional endoscopic surgery firstly was considered as an adenocarcinoma of low malignity degree but afterwards resulted as a mucinous cysto-adenoma of minor salivary glands with favorable clinical behaviour.